Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

GB:0QNV Stock Latest News

Company AnnouncementsAddex Boosts Issued Share Capital to Enhance Financing Flexibility3d ago

The FlyAddex Therapeutics spin-out company completes NTX-253 clinical studies3w agoADXN
Company AnnouncementsAddex Spin-Out Neurosterix Advances Schizophrenia Drug NTX-253 Into Phase 23w ago
Company AnnouncementsAddex Therapeutics Brings Back Veteran Chemist to Lead Pharmaceutical Development as Pipeline Enters New Phase1M ago
Company AnnouncementsAddex Therapeutics Earnings Call Highlights Pipeline Upside1M ago

Addex Raises Fresh Funds as It Regains GABAB Rights and Advances CNS Pipeline

Company AnnouncementsAddex Raises Fresh Funds as It Regains GABAB Rights and Advances CNS Pipeline1M ago

Company AnnouncementsAddex Regains Global Rights to Key GABAB Assets, Expands Neurology Portfolio1M ago

Company AnnouncementsAddex to Present Half-Year Results and Pipeline Update1M ago

Company AnnouncementsAddex Raises USD 2.8 Million, Extends Cash Runway to Late 20272M ago
The FlyAddex Therapeutics announces publication of new ADX71743 preclinical research3M agoADXN
Company AnnouncementsAddex bolsters mGlu7 program with new ADX71743 sleep and stress data3M ago
Company AnnouncementsAddex Shareholders Back Governance and Capital Changes at 2026 AGM4M ago

Company AnnouncementsAddex Therapeutics Balances Pipeline Progress and Cash Strain4M ago

Company AnnouncementsAddex Q1 Loss Widens as Cash Reserves Shrink While Neuro Spin-Out Advances4M ago

Company AnnouncementsAddex Therapeutics Sets Date for Q1 2026 Results and Pipeline Update4M ago

Company AnnouncementsAddex Sets 2026 AGM With Capital and Governance Changes on Agenda5M ago
Company AnnouncementsAddex Advances Neurology Pipeline but Swings to 2025 Net Loss6M ago
The FlyAddex Therapeutics announces GABAB PAM candidate data6M agoADXN
Company AnnouncementsAddex Posts Promising Preclinical Data for GABAB Modulator in IPF-Related Chronic Cough6M ago

Addex Therapeutics says spin-out company to complete NTX-253 study in Q2

The FlyAddex Therapeutics says spin-out company to complete NTX-253 study in Q26M agoADXN

Company AnnouncementsAddex Spin-Out Neurosterix Nears Completion of Phase 1 Schizophrenia Trial for NTX-2536M ago

Company AnnouncementsAddex Reports Robust Preclinical Efficacy for Novel GABAB Modulator in Chronic Cough6M ago